A report released by the analysts at QY Research in the domain of medical devices and consumables has provided an exclusive research, which offers a brief overview of the market. The report, titled, “Global Respiratory Distress Syndrome Market Research Report 2019”, focuses on information about key players and competitors across the world. The report ensures high level of accuracy, systematic research, and detailed valuation to the readers. The report is also based on the market numbers that cover the historical data and future estimates of the global respiratory distress syndrome market. The unique information of the report has been collected from the indirect as well as direct sources.
According to the report, the global respiratory distress syndrome market is expected to reach US$479 mn by 2025 from US$345 mn in 2018. The market will register a CAGR of 5.53% throughout the forecast period.
Global Respiratory Distress Syndrome Market: Trends and Opportunities
The global respiratory distress syndrome market will witness a remarkable growth due to a growing demand for effective treatment methods. Companies are focusing on the development of novel medicines to cure respiratory diseases. At present, non-profit organizations along with legislative bodies are taking part in raising awareness among the population about growing hazards of air pollution. The respiratory distress syndrome has the presence of limited players, which provides bulk opportunities to innovators because of high unmet needs. The market is expected to grow as respiratory distress syndrome continues to be a consistent health concern over the forecast period.
In addition, rapid development in the field of healthcare systems provides opportunities for increasing awareness about respiratory distress syndrome. The rising occurrence of respiratory distress syndrome along with a high rate of mortality will further drive the growth of the market in the coming years.
Global Respiratory Distress Syndrome Market: Segmentation
The global respiratory distress syndrome market is segmented into product type and application. The product type segment includes cell therapies, methylprednisolone, calf pulmonary surfactant for injection, hydrocortisone, and others. The application segment includes infants delivered by cesarean section, premature infants, and children of diabetic mothers.
Global Respiratory Distress Syndrome Market: Forecast by Regions
North America will dominate the global respiratory distress syndrome market because of the growing mortality rate of respiratory distress syndrome. Europe is also expected to drive the respiratory distress syndrome market because of well-established healthcare systems. Asia Pacific will also witness significant growth due to the increasing occurrence of respiratory distress syndrome and high birth rate of premature babies.
Global Respiratory Distress Syndrome Market: Key Players
Noargen, AbbVie Inc., Chiesi Farmaceutici S.p.A, and ONY Biotech are the four major players that are operating in the global market for respiratory distress syndrome.
Global Respiratory Distress Syndrome Market: Competitive Landscape
Manufacturers are predominantly focusing on the mergers and acquisitions, partnership, and new product development strategies, to keep up with the pace of the competition and develop innovative products to attain higher revenues.